Efficacy of Low Power Laser Therapy in Fibromyalgia: A Single-blind, Placebo-controlled Trial
✍ Scribed by A. Gür; M. Karakoç; K. Nas; R. Çevik; J. Saraç; E. Demir
- Publisher
- Springer-Verlag
- Year
- 2002
- Tongue
- English
- Weight
- 57 KB
- Volume
- 17
- Category
- Article
- ISSN
- 0268-8921
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## BACKGROUND The current study describes the results of a double blind, placebo‐controlled, randomized, single crossover trial of the treatment of patients with postmastectomy lymphedema (PML) with low‐level laser therapy (LLLT). ## METHODS Participants received placebo or one cycle
Fibromyalgia syndrome is a systemic disorder of widespread pain which is thought to result from abnormal pain processing within the central nervous system. There are no currently approved treatments for this indication. Antidepressants appear, however, to be effective, especially those with an actio
## Abstract ## Objective To assess the efficacy and safety of gabapentin in patients with fibromyalgia. ## Methods A 12‐week, randomized, double‐blind study was designed to compare gabapentin (1,200–2,400 mg/day) (n = 75 patients) with placebo (n = 75 patients) for efficacy and safety in treatin
## Abstract ## Background and Objectives A prospective, double‐blind, randomized, and controlled trial was conducted in patients with knee osteoarthritis (OA) to evaluate the efficacy of infrared low‐power Gallium‐Arsenide (Ga‐As) laser therapy (LPLT) and compared two different laser therapy regim